These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21768476)

  • 21. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy.
    Kim MJ; Kim JS; Cho SB
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):960-2. PubMed ID: 19207672
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficacy and safety of low-energy QS Nd:YAG and QS alexandrite laser for melasma].
    Wang HW; Liu KY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):45-7. PubMed ID: 19317058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
    Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
    Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of skin optical clearing efficacy using photo-irradiation.
    Liu C; Zhi Z; Tuchin VV; Luo Q; Zhu D
    Lasers Surg Med; 2010 Feb; 42(2):132-40. PubMed ID: 20166162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
    Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
    Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of Q-switched and quasi long-pulsed 1064-nm Nd:YAG laser, non-ablative 1450-nm diode laser, and ablative 10 600-nm carbon dioxide fractional laser for enlarged pores.
    Cho SB; Noh S; Lee SJ; Kang JM; Kim YK; Lee JH
    J Dermatolog Treat; 2010 Jul; 21(4):258-60. PubMed ID: 20509817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoin.
    Bonhomme L; Fredj G; Ecstein E; Maurisson G; Farabos C; Misset JL; Jasmin C
    Am J Hosp Pharm; 1994 Oct; 51(19):2417-9. PubMed ID: 7847408
    [No Abstract]   [Full Text] [Related]  

  • 29. [Kaposi's sarcoma].
    Castillo M
    Bol Asoc Med P R; 1983 Jun; 75(6):255-7. PubMed ID: 6577870
    [No Abstract]   [Full Text] [Related]  

  • 30. [Kaposi and Kaposi-AIDS. Cutaneous cancers in current practice].
    Belaich S
    Rev Prat; 1992 Sep; 42(14):1783-4. PubMed ID: 1480936
    [No Abstract]   [Full Text] [Related]  

  • 31. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
    J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monotherapy of endemic Kaposi sarcoma with long-term vincristine infusion].
    Haubenstock A; Malamud SC; Pipala JH; Mernick MH; DeVries K; Base W; Zalusky R
    Wien Klin Wochenschr; 1987 Apr; 99(7):239-42. PubMed ID: 3590803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Kaposi's sarcoma.
    Von Roenn JH; Cianfrocca M
    Cancer Treat Res; 2001; 104():127-48. PubMed ID: 11191125
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of various parameters of the 1064 nm Nd:YAG laser for the treatment of enlarged facial pores.
    Roh MR; Chung HJ; Chung KY
    J Dermatolog Treat; 2009; 20(4):223-8. PubMed ID: 19125363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New drug targets in Kaposi sarcoma.
    Sullivan RJ; Pantanowitz L
    Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Davener's dermatosis using a 1064-nm Q-switched Nd:YAG laser with low fluence.
    Cho S; Lee SJ; Lee JH; Cho SB
    Int J Dermatol; 2012 Nov; 51(11):1394-6. PubMed ID: 21974770
    [No Abstract]   [Full Text] [Related]  

  • 38. Spotted leucoderma after treatment of facial hyperpigmentation on hemodialysis patients employing 1064-nm Q-switched Nd:YAG laser.
    Hwang CY; Lin CS; Tseng ML; Liu HN
    J Cosmet Laser Ther; 2010 Feb; 12(1):47-50. PubMed ID: 19929290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suspected immune reconstitution inflammatory syndrome associated with the proliferation of Kaposi's sarcoma during HAART.
    Nathan RV
    AIDS; 2007 Mar; 21(6):775. PubMed ID: 17413703
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen.
    Kaplan L; Abrams D; Volberding P
    Cancer Treat Rep; 1986 Sep; 70(9):1121-2. PubMed ID: 3742492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.